LEONID BEGUN: Open Payments
NPI 1396208815 · WESTWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 45 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $389 · 2025 $1,085
Food & beverage: $946Education: $139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $289 |
| E.R. Squibb & Sons, L.L.C. | 12 | $286 |
| Teva Pharmaceuticals USA, Inc. | 11 | $258 |
| Neurocrine BioSciences, Inc. | 5 | $91 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $14 |
| Corium, LLC | 1 | $13 |
Products named: VRAYLAR, COBENFY, UZEDY, INGREZZA, Sunosi, REXULTI, Auvelity, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
